We propose that the NC1 α4(IV) domain be named “Tetrastatin”, to highlight the molecular origin of this matrikine, the α4(IV) collagen chain and its anti-tumor activity leading to a “stasis” of in vivo tumor growth, as defined for Hexastatin [18]. Here, COL18A1 is linked to neoplasm.